Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy
- Registration Number
- NCT03288428
- Lead Sponsor
- Peking University First Hospital
- Brief Summary
to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.
- Detailed Description
To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- elective Laparoscopic myomectomy patients 24hr post-operative patient controlled analgesia analgesia no mild or severe liver or renal disfunction
- can't understand patient controlled analgesia device refuse trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description nalbuphine Nalbuphine using nalbuphine for patient controlled analgesia morphine Morphine using morphine for patient controlled analgesia
- Primary Outcome Measures
Name Time Method numerical rating scale 24 hr post-operatively 1-10
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
First hospital Peking University
🇨🇳Beijing, Beijing, China